miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-335-5p | ||||
miRNA Stemloop AC | MI0000816 | ||||
miRNA Stemloop ID | hsa-mir-335 | ||||
Sequence | ucaagagcaauaacgaaaaaugu | ||||
TTD Target(s) Regulated by This miRNA | Insulin-like growth factor I receptor (IGF1R) | Successful Target | Target Info | [1] | |
Poly [ADP-ribose] polymerase 1 (PARP1) | Successful Target | Target Info | [2] | ||
C-X-C chemokine receptor type 4 (CXCR4) | Successful Target | Target Info | [3] | ||
Urokinase plasminogen activator surface receptor (PLAUR) | Successful Target | Target Info | [3] | ||
Rho-associated protein kinase 1 (ROCK1) | Successful Target | Target Info | [4] | ||
Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Target Info | [5] | ||
Apoptosis inhibitor survivin (BIRC5) | Clinical trial Target | Target Info | [6] | ||
Apoptosis regulator Bcl-W (BCL-W) | Clinical trial Target | Target Info | [7] | ||
Tyrosine-protein kinase Mer (MERTK) | Clinical trial Target | Target Info | [8] | ||
Dickkopf-related protein 1 (DKK1) | Clinical trial Target | Target Info | [9] | ||
Tenascin (TNC) | Clinical trial Target | Target Info | [10] | ||
Transcription factor Sp1 (SP1) | Clinical trial Target | Target Info | [11] | ||
Proto-oncogene c-Myc (MYC) | Literature-reported Target | Target Info | [8] | ||
Metabotropic glutamate receptor 4 (mGluR4) | Literature-reported Target | Target Info | [12] | ||
GTPase activating protein (RASA1) | Literature-reported Target | Target Info | [13] | ||
Zinc finger E-box-binding homeobox 2 (ZEB2) | Literature-reported Target | Target Info | [14] | ||
Disheveled-associated activator of morphogenesis 2 (DAAM2) | Literature-reported Target | Target Info | [15] | ||
Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Target Info | [16] | ||
Protein(s) Regulated by This miRNA | Actin-related protein 2/3 complex subunit 5-like protein | Regulated Protein | [17] | ||
Breast cancer type 1 susceptibility protein | Regulated Protein | [11] | |||
Crk-like protein | Regulated Protein | [19] | |||
DNA-binding protein inhibitor ID-4 | Regulated Protein | [11] | |||
E3 ubiquitin-protein ligase SIAH2 | Regulated Protein | [20] | |||
Epsin-2 | Regulated Protein | [11] | |||
Formin-2 | Regulated Protein | [15] | |||
Formin-like protein 3 | Regulated Protein | [15] | |||
Hepatocyte nuclear factor 3-beta | Regulated Protein | [22] | |||
Leucine-rich alpha-2-glycoprotein | Regulated Protein | [5] | |||
NEDD8-conjugating enzyme UBE2F | Regulated Protein | [8] | |||
POU domain, class 5, transcription factor 1 | Regulated Protein | [25] | |||
Receptor-type tyrosine-protein phosphatase N2 | Regulated Protein | [8] | |||
Retinoblastoma-associated protein | Regulated Protein | [26] | |||
Transcription elongation factor A protein-like 9 | Regulated Protein | [27] | |||
Transcription factor SOX-17 | Regulated Protein | [22] | |||
Transcription factor SOX-4 | Regulated Protein | [8] | |||
Trefoil factor 2 | Regulated Protein | [7] | |||
Tripartite motif-containing protein 29 | Regulated Protein | [29] | |||
References | |||||
REF 1 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010 Apr 2;141(1):129-41. | ||||
REF 2 | MiR-335 regulates the chemo-radioresistance of small cell lung cancer cells by targeting PARP-1. Gene. 2017 Feb 5;600:9-15. | ||||
REF 3 | Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells. J Cell Mol Med. 2015 Sep;19(9):2262-72. | ||||
REF 4 | miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013 Dec;384(1-2):105-11. | ||||
REF 5 | MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF- signalling pathway. Carcinogenesis. 2012 May;33(5):976-85. | ||||
REF 6 | Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. Biochem Biophys Res Commun. 2013 Jan 11;430(2):529-34. | ||||
REF 7 | MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene. 2012 Mar 15;31(11):1398-407. | ||||
REF 8 | Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008 Jan 10;451(7175):147-52. | ||||
REF 9 | MicroRNA-335-5p inhibits osteoblast apoptosis induced by high glucose. Mol Med Rep. 2016 May;13(5):4108-12. | ||||
REF 10 | miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis. Surgery. 2013 Aug;154(2):226-33. | ||||
REF 11 | MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011 Dec 15;129(12):2797-806. | ||||
REF 12 | MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4. Neurosci Lett. 2015 Oct 8;606:167-72. | ||||
REF 13 | Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer. Am J Cancer Res. 2014 Nov 19;4(6):648-62. | ||||
REF 14 | MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Med Oncol. 2014 Jun;31(6):982. | ||||
REF 15 | Metastasis suppressor microRNA-335 targets the formin family of actin nucleators. PLoS One. 2013 Nov 5;8(11):e78428. | ||||
REF 16 | miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 2011 Jun;18(6):985-95. | ||||
REF 17 | MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J. 2010 Jun;24(6):2030-9. | ||||
REF 18 | MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011 Dec 15;129(12):2797-806. | ||||
REF 19 | Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer.Cancer Cell Int. 2017 Feb 16;17:28. | ||||
REF 20 | miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3. Mol Cells. 2015 Jun;38(6):562-72. | ||||
REF 21 | Metastasis suppressor microRNA-335 targets the formin family of actin nucleators. PLoS One. 2013 Nov 5;8(11):e78428. | ||||
REF 22 | miR-335 promotes mesendodermal lineage segregation and shapes a transcription factor gradient in the endoderm.Development. 2014 Feb;141(3):514-25. | ||||
REF 23 | MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF- signalling pathway. Carcinogenesis. 2012 May;33(5):976-85. | ||||
REF 24 | Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008 Jan 10;451(7175):147-52. | ||||
REF 25 | MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.Tumour Biol. 2014 Aug;35(8):8309-18. | ||||
REF 26 | miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.Cancer Res. 2010 Sep 1;70(17):6925-33. | ||||
REF 27 | WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway.Br J Cancer. 2016 Jul 12;115(2):243-51. | ||||
REF 28 | MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene. 2012 Mar 15;31(11):1398-407. | ||||
REF 29 | Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.Oncotarget. 2016 Mar 22;7(12):13634-50. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.